Four molecular features can be used to group breast tumors based on the following: expression of the estrogen receptor (ER), the progesterone receptor (PR), Ki-67 (a proliferation index marker), and the HER2 receptor tyrosine kinase (HER2)4. This evidence concerns the gene ESR1 and breast neoplasm.